1Maxfield EK, Cameron NE, Cotter MA. Effects of diabetes on reactivity of sciatic vasa nervoran in rats[J] .J Diabetes Compl, 1997,11( 1 ) :47-55.
2Zimmermann PA, Knot HJ, Stevenson AS, et al. Increased myogenic tone and diminished responsiveness to ATP-sensitive K^+ channel openers in cerebral arteries from diabetic rats [ J ] . Circ Res, 1997,81 ( 7 ) :996-1004.
3Thrailkiu KM,Quattrin T, Baker L, et al. Cotherapy with recombinant insulin-like growth factor 1 and insulin improves glycomic control in type 1 diabetics [J] .Diabetes Care, 1999,22(4):585-.593.
4Janssen JA, Lambert S. Circulating IGF-1 and its protective role in the pathogenesis of diabetic angiopathy[ J]. Clin Endocrinol,2000,52( 1 ) :1-9.
5Tsutomu H, Kouichi K, Yasunori M, et al. Albuminuria is directly associated with increased plasma PAI-1 and factor Ⅶ levels in NIDDM patients[J]. Diabetes Res Clin Pract, 1997,36( 1 ) : 11-18.
6Fahumiya S, David J, Loskutoff M. The fat Mouse: a powerful genetic model to study elevated plasminogen activator inhibitor 1 in obesity/NIDDM[J]. Thromb Haemost, 1997,78(1) :652-655.
7Feener EP, King GL. Vascular dysfunction in diabetes mellitus [ J ].Lancet. 1997,350[Suppl 1 ] : S9-13.
8Ceriello A, falleti E, Bortoltli N, et al. Increased circulation inter cellular adhesion molecule-1 level in ripe Ⅱ diabetic patients:the possible role of matobolic control and oxidative stress [ J ] . Metabolism, 1996,45(4) :498.
9Peck LL,Funmi B,Amdrew D, et al.Plasma VEGF and soluble VEGF receptor FLT-I in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment [ J ]. Invest Ophthalmol Vis Sci, 2000,41(9) :2115-2119.
10Karamanos B, Porta M, Songini M, et al. Different risk factor of microangiopathy in patients with type Ⅰ diabetes menitus of short versus long duration. The eurodiabiddm complication study [ J ]. Diabetologla,2000,43(3) :348-355.
